We are live on
!
Find out more
SHCM
Sachem Head Capital Management Portfolio holdings
AUM
$4.15B
1-Year Est. Return
48.05%
This Fund
S&P 500
This Quarter
Est. Return
+14.04%
1 Year Est. Return
+48.05%
3 Year Est. Return
+105.55%
5 Year Est. Return
+99.81%
10 Year Est. Return
+787.49%
AUM
$1.51B
AUM Growth
+$166M
(+12%)
Cap. Flow
+$17.8M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$106M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$34.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$93.7M |
| 2 |
Viatris
VTRS
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.39% |
| 2 | Industrials | 39.17% |
| 3 | Materials | 8.72% |
| 4 | Communication Services | 4.42% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDK
1
DELISTED
CDK Global, Inc.
CDK
| $591M | 39.17% |
12,647,333
| – | – |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $238M | 15.77% |
800,000
| – | – |
|
3
Zoetis
ZTS
$31.9B
| $203M | 13.47% |
4,395,000
| – | – |
|
4
Air Products & Chemicals
APD
$66.8B
| $132M | 8.72% |
940,470
| – | – |
|
|
SLXP
5
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $125M | 8.31% |
+725,000
| New | +$106M |
|
|
6
Viatris
VTRS
$20.7B
| $115M | 7.64% |
1,945,000
-520,000
| -21% | -$29.6M |
|
|
TFCFA
7
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $66.7M | 4.42% |
1,971,762
| – | – |
|
|
8
Bio-Rad Laboratories Class A
BIO
$8.74B
| $37.9M | 2.51% |
+280,000
| New | +$34.7M |
|
|
9
Dollar General
DG
$28.1B
| – | – |
-1,325,000
| Closed | -$93.7M |
|
Similar funds
ZP
GCM
SP
BOK
AP
HIP
BHC
BG
Sachem Head Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Sachem Head Capital Management held 9 positions worth $1.51B, up 12% from $1.34B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Sachem Head Capital Management's Q1 2015 filing shows 2 new, 1 reduced and 1 closed positions. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 725,000 shares worth $125M. The largest sale was Dollar General, an estimated $93.7M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Industrials and Materials.
- Sachem Head Capital Management's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 725,000 shares worth $125M.
- Sachem Head Capital Management's biggest Q1 2015 reduction was Viatris, cutting an estimated $29.6M.
- Sachem Head Capital Management fully exited Dollar General in Q1 2015, selling an estimated $93.7M.
- Sachem Head Capital Management's ten largest holdings make up 100% of its $1.51B portfolio in Q1 2015.
- Sachem Head Capital Management opened 2 new positions and closed 1 in Q1 2015.
- Sachem Head Capital Management's portfolio value rose 12% quarter-over-quarter to $1.51B.
Based on Sachem Head Capital Management's 13F filing for Q1 2015, filed 15 May 2015.